References
- Adcock, I.M. 1996. Steroid resistance in asthma. Molecular mechanisms. Am. J. Respir. Crit. Care Med. 154, S58-61 https://doi.org/10.1164/ajrccm/154.2_Pt_2.S58
- Beliveau, R., D. Gingras, E.A. Kruger, S. Lamy, P. Sirois, B. Simard, M.G. Sirois, L. Tranqui, F. Baffert, E. Beaulieu, V. Dimitriadou, M.C. Pepin, F. Courjal, I. Ricard, P. Poyet, P. Falardeau, W.D. Figg, and E. Dupont. 2002. The antiangiogenic agent neovastat (AE-941) inhibits vascular endothelial growth factor-mediated biological effects. Clin. Cancer Res. 8, 1242-1250
-
Boivin, D., S. Gendron, Beaulieu, D. Gingras, and R. Beliveau. 2002. The Antiangiogenic Agent Neovastat (
${\AE}$ -941) Induces Endothelial Cell Apoptosis. Molecular Cancer Therapeutics. 1, 795-802 - Castronovo, V., V. Dimitriadou, P. Savard, M. Riviere, and E. Dupont. 1999. Cartilage as a source of natural inhibitors of angiogenesis. Antiangiogenic Agents in Cancer Therapy, p. 175-83. Humana Press, Totowa, New Jersey
-
Cho, J.Y., M. Miller, K.J. Baek, G. W. Han, J. Nayar, M. Rodriguez, S.Y. Lee, K. McElwain, S. McElwain, E. Raz, and D.H. Broide. 2004. Immunostimulatory DNA Inhibits Transforming Growth Factor-
$\beta$ Expression and Airway Remodeling. Am. J. Respir. Cell Mol. Biol. 30, 651-661 https://doi.org/10.1165/rcmb.2003-0066OC - Delcaux, C., C. Delacourt, M.P. d'Ortho, V. Boyer, C. Lafuma, and A. Harf. 1996. Role of gelatinase B and elastase in human polymorphonuclear neutrohil migration across basement membrane. Am. J. Respir. Cell Mol. Biol. 14, 288-295 https://doi.org/10.1165/ajrcmb.14.3.8845180
- Dunnill, M.S. 1960. The pathology of asthma with special reference to changes in the bronchial mucosa. J. Clin. Patho. 13, 27-33 https://doi.org/10.1136/jcp.13.1.27
-
Falardeau, P., P. Champagne, P. Poyet, C. Hariton, and E, Dupont. 2001.
${\AE}$ -941 (Neovastat), a naturally occurring multifunctional anti-angiogenic product in Phase clinical trials. Semin. Oncol. 28, 620-625 -
Gingras, D., A. Renaud, N. Mousseau, E. Beaulieu, Z. Kachra, and R. Beliveau. 2001. Matrix proteinase Inhibition by
${\AE}$ -941, a multifunctional antiangiogenic compound. Anticancer Res. 21, 145-155 -
Gingras, D., G. Batist, and R. Beliveau. 2001.
${\AE}$ -941 (Neovastat$^{\circledR}$ ): A novel multifunctional antiangiogenic compound. Expert Rev. Anticancer Ther. 1, 341-347 https://doi.org/10.1586/14737140.1.3.341 - Jonathan, P.A. and T.H. Lee. 1992. The pathobiology of bronchial asthma. Adv. Immunol. 51, 323-329 https://doi.org/10.1016/S0065-2776(08)60491-5
- Kelly, E.A. and N.N. Jarjour. 2003. Role of matrix metalloproteinases in asthma. Current Opinion in Pulmonary Medicine. 9, 28-33 https://doi.org/10.1097/00063198-200301000-00005
- Kumagai, K., I. Ohno, S. Okada, Y. Ohkawara, S.K. uzuki, T. Shinya, H. Nagase, K. Iwata, and S.K. hirato. 1999. Inhibition of matrix metalloproteinases prevents allergen-induced airway inflammation in a murine model of asthma. J. Immunol. 162, 4212-4219
- Lee, Y.C., C.H. Song, H.B. Lee, J.L. Oh, Y.K. Rhee, H.S. Park, and G.Y. Koh. 2001. A murine model of toluene diisocyanate-induced asthma can be treated with matrix metalloproteinase inhibitor. J. Allergy Clin. Immunol. 108, 1021-1026 https://doi.org/10.1067/mai.2001.120132
- Lee, K.S., S.M. Jin, H.J. Kim, and Y.C. Lee. 2003. Matrix metalloproteinase inhibitor regulates inflammatory cell migration by reducing ICAM-1 and VCAM-1 expression in a murine model of toluene diisocyanate-induced asthma. J. Allergy Clin. Immunol. 111, 1278-1284 https://doi.org/10.1067/mai.2003.1501
- Leppert, D., E. Waubant, R. Galardy, N.W. Bunnett, and S.L. Hauser. 1995. T cell gelatinases mediate basement membrane transmigration in vitro. J. Immunol. 154, 4379-4389
- Li, X. and J.W. Wilson. 1997. Increased vascularity of the bronchial mucosa in mild asthma. Am. J. Respir. Crit. Card. Med. 156, 229-233 https://doi.org/10.1164/ajrccm.156.1.9607066
- Lukacs, N.W. 2000. Migration of helper T-lymphocyte subsets into inflamed tissues. J. Allergy Clin. Immunol. 106, 264-269 https://doi.org/10.1067/mai.2000.110160
- Mautino, G., N. Oliver, P. chanez, J. Bousquet, and F. Capony. 1997. Increased release of matrix metalloproteinase-9 in bronchoalveolar lavage fluid and by alveolar macrophgages of asthmatics. Am. J. Respir. Cell Mol. Biol. 17, 583-591 https://doi.org/10.1165/ajrcmb.17.5.2562
- Nagase, H. 1997. Activation mechanisms of matrix metalloproteinases. Biol. Chem. 378, 151-160
- Okada, S., H. Kita, T.J. George, G.J. Gleich, and K.M. Leiferman. 1997. Migration of eosinophil through basement membrane components in vitro:role of matrix metalloproteinase-9. Am. J. Respir. Cell Mol. Biol. 17, 519-528 https://doi.org/10.1165/ajrcmb.17.4.2877
- Stetler-Stevenson, W.G., H.C. Krutzsch, and L.A. Liotta. 1989. Tissue inhibitor of metalloproteinase (TIMP-2): A new member of the metalloproteinase family. J. Biol Chem. 264, 17374-17378
- Sternlicht, M.D. and Z. Werb. 2001. How Matrix Metalloproteinases Regulate Cell Behavior. Ann. Rev. Cell Dev. Biol. 17, 463-516 https://doi.org/10.1146/annurev.cellbio.17.1.463
- Stricklin, G. and H. Welgus. 1983. Human skin fibroblasts collagenase inhibitor : purification and biochemical characterization. J. Biol. Chem. 258, 12252-12258
- Yang, H., S. Han, H. Kim, Y.M. Choi, K.J. Hwang, H.C. Kwon, S.K. Kim, and D.J. Cho. 2002. Expression of integrines, cyclooxygenases and matrix metalloproteinases in threedimensional human endometrial cell culture system. Exp. Mol. Med. 34, 75-82 https://doi.org/10.1038/emm.2002.11
- Van Eerdewegh, P., R.D. Little, and J. Dupuis. 2002. Association of the ADAM33 gene with asthma and bronchial hyperresponsiveness. Nature 418, 426-430 https://doi.org/10.1038/nature00878
- Warner, J.A., P. Julius, W. Luttmann, and C. Kroegel. 1997. Matrix metalloproteinases in bronchoalveolar lavage fluid following antigen challenge. Int. Arch. Allergy Immunol. 113, 318-320 https://doi.org/10.1159/000237587